Description
Glutathione (γ-L-glutamyl-L-cysteinyl-glycine) is the most abundant intracellular antioxidant tripeptide, synthesized endogenously from its three constituent amino acids and serving as the hub of cellular redox regulation, detoxification, and immune function.
Research Overview
Decades of research have established glutathione’s central role in neutralizing reactive oxygen species (ROS) through direct reduction and as a cofactor for glutathione peroxidases and peroxiredoxins. The GSH/GSSG (reduced/oxidized) ratio is widely used as a marker of cellular oxidative stress status in research models. Phase II detoxification research has characterized glutathione S-transferases as enzymes conjugating GSH to electrophilic toxins and carcinogens for urinary excretion. Studies consistently document age-related decline in intracellular GSH levels, correlating with increased markers of oxidative damage. Bioavailability research has shown that conventional oral supplementation is subject to gastrointestinal hydrolysis by gamma-glutamyltranspeptidase, motivating study of alternative delivery approaches (liposomal, IV, and precursor-based). Dermatological research has examined glutathione’s role in melanin pathway modulation via tyrosinase inhibition, with a systematic review in Clinical, Cosmetic and Investigational Dermatology (2017) summarizing findings across multiple administration methods. Lymphocyte proliferation, NK cell cytotoxicity, and cytokine production have all been studied as immune readouts of GSH status. Teams extending this research continue to examine delivery mechanisms and tissue-specific GSH repletion strategies.
Key References
- Sies H. (1999). Glutathione and its role in cellular functions. Free Radical Biology and Medicine.
- Weschawalit S et al. (2017). Glutathione and its antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology.
- Dröge W, Breitkreutz R. (2000). Glutathione and immune function. Proceedings of the Nutrition Society.





Reviews
There are no reviews yet.